Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
HMS faculty, help us improve the algorithms in Profiles by
uploading your CV!
Return to Top
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov. 2014 Jul; 4(7):816-27.
View in:
PubMed
subject areas
Anilides
Benzimidazoles
Benzocycloheptenes
Cell Line, Tumor
Cells, Cultured
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Hepatocyte Growth Factor
Humans
Indoles
MAP Kinase Signaling System
Melanocytes
Melanoma
Microphthalmia-Associated Transcription Factor
NF-kappa B p50 Subunit
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins c-met
Pyridines
Quinolines
Sulfonamides
Triazoles
authors with profiles
Adriano Piris, M.D.
Keith Thomas Flaherty, M.D.
William Chun Hahn, Ph.D., M.D.
Rizwan Haq, Ph.D., M.D.
David Erich Fisher, M.D., Ph.D.